Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Amortization - IntangiblesConsolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Income from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)
Others
Ratios

Dianthus Therapeutics (DNTH) Profit After Tax: 2016-2024

Historic Profit After Tax for Dianthus Therapeutics (DNTH) over the last 7 years, with Dec 2024 value amounting to -$85.0 million.

  • Dianthus Therapeutics' Profit After Tax fell 46.04% to -$36.8 million in Q3 2025 from the same period last year, while for Sep 2025 it was -$126.4 million, marking a year-over-year decrease of 88.26%. This contributed to the annual value of -$85.0 million for FY2024, which is 94.95% down from last year.
  • Latest data reveals that Dianthus Therapeutics reported Profit After Tax of -$85.0 million as of FY2024, which was down 94.95% from -$43.6 million recorded in FY2023.
  • Over the past 5 years, Dianthus Therapeutics' Profit After Tax peaked at -$28.5 million during FY2022, and registered a low of -$85.0 million during FY2024.
  • Moreover, its 3-year median value for Profit After Tax was -$43.6 million (2023), whereas its average is -$52.4 million.
  • Data for Dianthus Therapeutics' Profit After Tax shows a maximum YoY tumbled of 94.95% (in 2024) over the last 5 years.
  • Over the past 3 years, Dianthus Therapeutics' Profit After Tax (Yearly) stood at -$28.5 million in 2022, then plummeted by 52.98% to -$43.6 million in 2023, then slumped by 94.95% to -$85.0 million in 2024.